-
1
-
-
14244265590
-
Epidemiology and etiology of gliomas
-
15685439
-
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93-108
-
(2005)
Acta Neuropathol
, vol.109
, pp. 93-108
-
-
Ohgaki, H.1
Kleihues, P.2
-
2
-
-
0033581097
-
Cancer surveillance series [corrected]: Brain and other central nervous system cancers: Recent trends in incidence and mortality
-
10451443
-
Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382-1390
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1382-1390
-
-
Legler, J.M.1
Ries, L.A.2
Smith, M.A.3
Warren, J.L.4
Heineman, E.F.5
Kaplan, R.S.6
Linet, M.S.7
-
4
-
-
84874091180
-
The definition of primary and secondary glioblastoma
-
23209033
-
Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764-772
-
(2013)
Clin Cancer Res
, vol.19
, pp. 764-772
-
-
Ohgaki, H.1
Kleihues, P.2
-
6
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
15758009
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
7
-
-
47949131646
-
Antiangiogenics and radiotherapy
-
18644195
-
Shannon AM, Williams KJ (2008) Antiangiogenics and radiotherapy. J Pharm Pharmacol 60:1029-1036
-
(2008)
J Pharm Pharmacol
, vol.60
, pp. 1029-1036
-
-
Shannon, A.M.1
Williams, K.J.2
-
8
-
-
0038523737
-
Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
-
12758235
-
Bussink J, Kaanders JH, van der Kogel AJ (2003) Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67:3-15
-
(2003)
Radiother Oncol
, vol.67
, pp. 3-15
-
-
Bussink, J.1
Kaanders, J.H.2
Van Der Kogel, A.J.3
-
9
-
-
34948820602
-
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
-
17704786
-
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andre F, Delaloge S, Tursz T, Kroemer G, Zitvogel L (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050-1059
-
(2007)
Nat Med
, vol.13
, pp. 1050-1059
-
-
Apetoh, L.1
Ghiringhelli, F.2
Tesniere, A.3
Obeid, M.4
Ortiz, C.5
Criollo, A.6
Mignot, G.7
Maiuri, M.C.8
Ullrich, E.9
Saulnier, P.10
Yang, H.11
Amigorena, S.12
Ryffel, B.13
Barrat, F.J.14
Saftig, P.15
Levi, F.16
Lidereau, R.17
Nogues, C.18
Mira, J.P.19
Chompret, A.20
Joulin, V.21
Clavel-Chapelon, F.22
Bourhis, J.23
Andre, F.24
Delaloge, S.25
Tursz, T.26
Kroemer, G.27
Zitvogel, L.28
more..
-
10
-
-
4544317760
-
Macrophages enhance the radiosensitizing activity of lipid A: A novel role for immune cells in tumor cell radioresponse
-
15380597
-
De Ridder M, Verovski VN, Darville MI, Van Den Berge DL, Monsaert C, Eizirik DL, Storme GA (2004) Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse. Int J Radiat Oncol Biol Phys 60:598-606
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 598-606
-
-
De Ridder, M.1
Verovski, V.N.2
Darville, M.I.3
Van Den Berge, D.L.4
Monsaert, C.5
Eizirik, D.L.6
Storme, G.A.7
-
11
-
-
0026006501
-
Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
-
1718748
-
Coffer PJ, Woodgett JR (1991) Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem 201:475-481
-
(1991)
Eur J Biochem
, vol.201
, pp. 475-481
-
-
Coffer, P.J.1
Woodgett, J.R.2
-
12
-
-
0025882091
-
Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
-
51620 1851997
-
Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA (1991) Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88:4171-4175
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 4171-4175
-
-
Jones, P.F.1
Jakubowicz, T.2
Pitossi, F.J.3
Maurer, F.4
Hemmings, B.A.5
-
13
-
-
0026095665
-
A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
-
1833819
-
Bellacosa A, Testa JR, Staal SP, Tsichlis PN (1991) A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274-277
-
(1991)
Science
, vol.254
, pp. 274-277
-
-
Bellacosa, A.1
Testa, J.R.2
Staal, S.P.3
Tsichlis, P.N.4
-
14
-
-
0037032835
-
The protein kinase complement of the human genome
-
12471243
-
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912-1934
-
(2002)
Science
, vol.298
, pp. 1912-1934
-
-
Manning, G.1
Whyte, D.B.2
Martinez, R.3
Hunter, T.4
Sudarsanam, S.5
-
15
-
-
54949109808
-
PI3K/Akt: Getting it right matters
-
18955974
-
Franke TF (2008) PI3K/Akt: getting it right matters. Oncogene 27:6473-6488
-
(2008)
Oncogene
, vol.27
, pp. 6473-6488
-
-
Franke, T.F.1
-
16
-
-
78649712949
-
MTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide
-
3020639 21045808
-
Oh WJ, Wu CC, Kim SJ, Facchinetti V, Julien LA, Finlan M, Roux PP, Su B, Jacinto E (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J 29:3939-3951
-
(2010)
EMBO J
, vol.29
, pp. 3939-3951
-
-
Oh, W.J.1
Wu, C.C.2
Kim, S.J.3
Facchinetti, V.4
Julien, L.A.5
Finlan, M.6
Roux, P.P.7
Su, B.8
Jacinto, E.9
-
17
-
-
47949125486
-
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
-
2486276 18566586
-
Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C, Lowry C, Newton AC, Mao Y, Miao RQ, Sessa WC, Qin J, Zhang P, Su B, Jacinto E (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 27:1932-1943
-
(2008)
EMBO J
, vol.27
, pp. 1932-1943
-
-
Facchinetti, V.1
Ouyang, W.2
Wei, H.3
Soto, N.4
Lazorchak, A.5
Gould, C.6
Lowry, C.7
Newton, A.C.8
Mao, Y.9
Miao, R.Q.10
Sessa, W.C.11
Qin, J.12
Zhang, P.13
Su, B.14
Jacinto, E.15
-
18
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
15718470
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
19
-
-
4644359805
-
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase
-
15262962
-
Feng J, Park J, Cron P, Hess D, Hemmings BA (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279:41189-41196
-
(2004)
J Biol Chem
, vol.279
, pp. 41189-41196
-
-
Feng, J.1
Park, J.2
Cron, P.3
Hess, D.4
Hemmings, B.A.5
-
20
-
-
60549096247
-
Akt-dependent and -independent mechanisms of mTOR regulation in cancer
-
2650010 19166931
-
Memmott RM, Dennis PA (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal 21:656-664
-
(2009)
Cell Signal
, vol.21
, pp. 656-664
-
-
Memmott, R.M.1
Dennis, P.A.2
-
21
-
-
84862103119
-
PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics
-
3358464 22307544
-
Mahajan K, Mahajan NP (2012) PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics. J Cell Physiol 227:3178-3184
-
(2012)
J Cell Physiol
, vol.227
, pp. 3178-3184
-
-
Mahajan, K.1
Mahajan, N.P.2
-
22
-
-
0033551070
-
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
-
33561 10200246
-
Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 4240-4245
-
-
Cantley, L.C.1
Neel, B.G.2
-
23
-
-
80052275615
-
PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains
-
3167518 21873248
-
Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW, Zhang J (2011) PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci USA 108:14509-14514
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 14509-14514
-
-
Gao, X.1
Lowry, P.R.2
Zhou, X.3
Depry, C.4
Wei, Z.5
Wong, G.W.6
Zhang, J.7
-
24
-
-
15944406764
-
PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth
-
15808505
-
Gao T, Furnari F, Newton AC (2005) PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18:13-24
-
(2005)
Mol Cell
, vol.18
, pp. 13-24
-
-
Gao, T.1
Furnari, F.2
Newton, A.C.3
-
25
-
-
84878431342
-
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
-
23454242
-
Seshacharyulu P, Pandey P, Datta K, Batra SK (2013) Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett 335:9-18
-
(2013)
Cancer Lett
, vol.335
, pp. 9-18
-
-
Seshacharyulu, P.1
Pandey, P.2
Datta, K.3
Batra, S.K.4
-
26
-
-
33947203621
-
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms
-
17386267
-
Brognard J, Sierecki E, Gao T, Newton AC (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25:917-931
-
(2007)
Mol Cell
, vol.25
, pp. 917-931
-
-
Brognard, J.1
Sierecki, E.2
Gao, T.3
Newton, A.C.4
-
27
-
-
84862931549
-
LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway
-
22086271
-
Chen L, Han L, Shi Z, Zhang K, Liu Y, Zheng Y, Jiang T, Pu P, Jiang C, Kang C (2012) LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway. Mol Med Rep 5:575-579
-
(2012)
Mol Med Rep
, vol.5
, pp. 575-579
-
-
Chen, L.1
Han, L.2
Shi, Z.3
Zhang, K.4
Liu, Y.5
Zheng, Y.6
Jiang, T.7
Pu, P.8
Jiang, C.9
Kang, C.10
-
28
-
-
23944526062
-
Activation of AKT kinases in cancer: Implications for therapeutic targeting
-
16095999
-
Bellacosa A, Kumar CC, Di Cristofano A, Testa JR (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94:29-86
-
(2005)
Adv Cancer Res
, vol.94
, pp. 29-86
-
-
Bellacosa, A.1
Kumar, C.C.2
Di Cristofano, A.3
Testa, J.R.4
-
29
-
-
0029127042
-
Benedetti Panici P, Mancuso S, Neri G, Testa JR: Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
-
7657393
-
Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G (1995) Benedetti Panici P, Mancuso S, Neri G, Testa JR: Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280-285
-
(1995)
Int J Cancer
, vol.64
, pp. 280-285
-
-
Bellacosa, A.1
De Feo, D.2
Godwin, A.K.3
Bell, D.W.4
Cheng, J.Q.5
Altomare, D.A.6
Wan, M.7
Dubeau, L.8
Scambia, G.9
Masciullo, V.10
Ferrandina, G.11
-
30
-
-
0001457668
-
Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
-
39663 8622988
-
Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636-3641
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 3636-3641
-
-
Cheng, J.Q.1
Ruggeri, B.2
Klein, W.M.3
Sonoda, G.4
Altomare, D.A.5
Watson, D.K.6
Testa, J.R.7
-
31
-
-
0030860466
-
Transforming activity and mitosis-related expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis
-
9190895
-
Cheng JQ, Altomare DA, Klein MA, Lee WC, Kruh GD, Lissy NA, Testa JR (1997) Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14:2793-2801
-
(1997)
Oncogene
, vol.14
, pp. 2793-2801
-
-
Cheng, J.Q.1
Altomare, D.A.2
Klein, M.A.3
Lee, W.C.4
Kruh, G.D.5
Lissy, N.A.6
Testa, J.R.7
-
32
-
-
0001582482
-
Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
-
305241 3037531
-
Staal SP (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A 84:5034-5037
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 5034-5037
-
-
Staal, S.P.1
-
33
-
-
0033618371
-
Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
-
10419456
-
Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ, Roth RA (1999) Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274:21528-21532
-
(1999)
J Biol Chem
, vol.274
, pp. 21528-21532
-
-
Nakatani, K.1
Thompson, D.A.2
Barthel, A.3
Sakaue, H.4
Liu, W.5
Weigel, R.J.6
Roth, R.A.7
-
34
-
-
77952309277
-
Akt2 and Akt3 play a pivotal role in malignant gliomas
-
2940586 20167810
-
Mure H, Matsuzaki K, Kitazato KT, Mizobuchi Y, Kuwayama K, Kageji T, Nagahiro S (2010) Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro Oncol 12:221-232
-
(2010)
Neuro Oncol
, vol.12
, pp. 221-232
-
-
Mure, H.1
Matsuzaki, K.2
Kitazato, K.T.3
Mizobuchi, Y.4
Kuwayama, K.5
Kageji, T.6
Nagahiro, S.7
-
35
-
-
0038615946
-
Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo
-
12782577
-
Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS (2003) Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742-2746
-
(2003)
Cancer Res
, vol.63
, pp. 2742-2746
-
-
Choe, G.1
Horvath, S.2
Cloughesy, T.F.3
Crosby, K.4
Seligson, D.5
Palotie, A.6
Inge, L.7
Smith, B.L.8
Sawyers, C.L.9
Mischel, P.S.10
-
36
-
-
0032558822
-
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
-
9799739
-
Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8:1195-1198
-
(1998)
Curr Biol
, vol.8
, pp. 1195-1198
-
-
Haas-Kogan, D.1
Shalev, N.2
Wong, M.3
Mills, G.4
Yount, G.5
Stokoe, D.6
-
37
-
-
0025114687
-
Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
-
55005 2236070
-
Sugawa N, Ekstrand AJ, James CD, Collins VP (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602-8606
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 8602-8606
-
-
Sugawa, N.1
Ekstrand, A.J.2
James, C.D.3
Collins, V.P.4
-
38
-
-
0029666423
-
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor
-
8700557
-
Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, Wong MY, Wong AJ (1996) Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene 13:85-96
-
(1996)
Oncogene
, vol.13
, pp. 85-96
-
-
Moscatello, D.K.1
Montgomery, R.B.2
Sundareshan, P.3
McDanel, H.4
Wong, M.Y.5
Wong, A.J.6
-
39
-
-
34547881522
-
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
-
1937558 17646646
-
Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM (2007) Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci USA 104:12867-12872
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 12867-12872
-
-
Huang, P.H.1
Mukasa, A.2
Bonavia, R.3
Flynn, R.A.4
Brewer, Z.E.5
Cavenee, W.K.6
Furnari, F.B.7
White, F.M.8
-
40
-
-
84867505054
-
PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome
-
3424210 22753230
-
Mueller S, Phillips J, Onar-Thomas A, Romero E, Zheng S, Wiencke JK, McBride SM, Cowdrey C, Prados MD, Weiss WA, Berger MS, Gupta N, Haas-Kogan DA (2012) PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Neuro Oncol 14:1146-1152
-
(2012)
Neuro Oncol
, vol.14
, pp. 1146-1152
-
-
Mueller, S.1
Phillips, J.2
Onar-Thomas, A.3
Romero, E.4
Zheng, S.5
Wiencke, J.K.6
McBride, S.M.7
Cowdrey, C.8
Prados, M.D.9
Weiss, W.A.10
Berger, M.S.11
Gupta, N.12
Haas-Kogan, D.A.13
-
41
-
-
77956288767
-
Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation
-
2932801 20736378
-
Molina JR, Morales FC, Hayashi Y, Aldape KD, Georgescu MM (2010) Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Cancer Res 70:6697-6703
-
(2010)
Cancer Res
, vol.70
, pp. 6697-6703
-
-
Molina, J.R.1
Morales, F.C.2
Hayashi, Y.3
Aldape, K.D.4
Georgescu, M.M.5
-
42
-
-
3543056884
-
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas
-
15184909
-
Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN (2004) Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest 84:941-951
-
(2004)
Lab Invest
, vol.84
, pp. 941-951
-
-
Wang, H.1
Zhang, W.2
Huang, H.J.3
Liao, W.S.4
Fuller, G.N.5
-
43
-
-
84858958769
-
Expression of pERK and pAKT in pediatric high grade astrocytomas: Correlation with YKL40 and prognostic significance
-
21978279
-
Antonelli M, Massimino M, Morra I, Garre ML, Gardiman MP, Buttarelli FR, Arcella A, Giangaspero F (2012) Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance. Neuropathology 32:133-138
-
(2012)
Neuropathology
, vol.32
, pp. 133-138
-
-
Antonelli, M.1
Massimino, M.2
Morra, I.3
Garre, M.L.4
Gardiman, M.P.5
Buttarelli, F.R.6
Arcella, A.7
Giangaspero, F.8
-
44
-
-
79954447261
-
PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma
-
3417062 21113787
-
Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, Gilmer-Flynn H, Sarkaria JN, Jenkins S, Long J, Rodriguez FJ (2011) PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 121:407-420
-
(2011)
Acta Neuropathol
, vol.121
, pp. 407-420
-
-
Rodriguez, E.F.1
Scheithauer, B.W.2
Giannini, C.3
Rynearson, A.4
Cen, L.5
Hoesley, B.6
Gilmer-Flynn, H.7
Sarkaria, J.N.8
Jenkins, S.9
Long, J.10
Rodriguez, F.J.11
-
45
-
-
77954008271
-
Higher pAkt expression predicts a significant worse prognosis in glioblastomas
-
20410674
-
Suzuki Y, Shirai K, Oka K, Mobaraki A, Yoshida Y, Noda SE, Okamoto M, Itoh J, Itoh H, Ishiuchi S, Nakano T (2010) Higher pAkt expression predicts a significant worse prognosis in glioblastomas. J Radiat Res 51:343-348
-
(2010)
J Radiat Res
, vol.51
, pp. 343-348
-
-
Suzuki, Y.1
Shirai, K.2
Oka, K.3
Mobaraki, A.4
Yoshida, Y.5
Noda, S.E.6
Okamoto, M.7
Itoh, J.8
Itoh, H.9
Ishiuchi, S.10
Nakano, T.11
-
46
-
-
0034020459
-
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
-
10802656
-
Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55-57
-
(2000)
Nat Genet
, vol.25
, pp. 55-57
-
-
Holland, E.C.1
Celestino, J.2
Dai, C.3
Schaefer, L.4
Sawaya, R.E.5
Fuller, G.N.6
-
47
-
-
0035884505
-
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma
-
11559533
-
Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674-6678
-
(2001)
Cancer Res
, vol.61
, pp. 6674-6678
-
-
Sonoda, Y.1
Ozawa, T.2
Aldape, K.D.3
Deen, D.F.4
Berger, M.S.5
Pieper, R.O.6
-
48
-
-
84874519918
-
Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish
-
3578497 23325864
-
Jung IH, Leem GL, Jung DE, Kim MH, Kim EY, Kim SH, Park HC, Park SW (2013) Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish. Neuro Oncol 15:290-304
-
(2013)
Neuro Oncol
, vol.15
, pp. 290-304
-
-
Jung, I.H.1
Leem, G.L.2
Jung, D.E.3
Kim, M.H.4
Kim, E.Y.5
Kim, S.H.6
Park, H.C.7
Park, S.W.8
-
49
-
-
34548266099
-
AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines
-
17426444
-
Koseoglu S, Lu Z, Kumar C, Kirschmeier P, Zou J (2007) AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol Ther 6:755-762
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 755-762
-
-
Koseoglu, S.1
Lu, Z.2
Kumar, C.3
Kirschmeier, P.4
Zou, J.5
-
50
-
-
0036185848
-
The protein kinase B/Akt signalling pathway in human malignancy
-
11882383
-
Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381-395
-
(2002)
Cell Signal
, vol.14
, pp. 381-395
-
-
Nicholson, K.M.1
Anderson, N.G.2
-
51
-
-
34250788809
-
AKT/PKB signaling: Navigating downstream
-
2756685 17604717
-
Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
-
(2007)
Cell
, vol.129
, pp. 1261-1274
-
-
Manning, B.D.1
Cantley, L.C.2
-
52
-
-
0032484019
-
CREB is a regulatory target for the protein kinase Akt/PKB
-
9829964
-
Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377-32379
-
(1998)
J Biol Chem
, vol.273
, pp. 32377-32379
-
-
Du, K.1
Montminy, M.2
-
53
-
-
0033517189
-
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
-
10485710
-
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85
-
(1999)
Nature
, vol.401
, pp. 82-85
-
-
Ozes, O.N.1
Mayo, L.D.2
Gustin, J.A.3
Pfeffer, S.R.4
Pfeffer, L.M.5
Donner, D.B.6
-
54
-
-
28044461715
-
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma
-
16275989
-
Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK (2005) Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4:1681-1688
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 1681-1688
-
-
Koul, D.1
Shen, R.2
Bergh, S.3
Lu, Y.4
De Groot, J.F.5
Liu, T.J.6
Mills, G.B.7
Yung, W.K.8
-
55
-
-
19944411156
-
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
-
15782140
-
Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24:3596-3605
-
(2005)
Oncogene
, vol.24
, pp. 3596-3605
-
-
Edwards, L.A.1
Thiessen, B.2
Dragowska, W.H.3
Daynard, T.4
Bally, M.B.5
Dedhar, S.6
-
56
-
-
38349111410
-
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)
-
18202010
-
Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, Chiu G, Rajput A, Kyle AH, Kalra J, Yapp D, Yan H, Minchinton AI, Huntsman D, Daynard T, Waterhouse DN, Thiessen B, Dedhar S, Bally MB (2008) Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). Mol Cancer Ther 7:59-70
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 59-70
-
-
Edwards, L.A.1
Woo, J.2
Huxham, L.A.3
Verreault, M.4
Dragowska, W.H.5
Chiu, G.6
Rajput, A.7
Kyle, A.H.8
Kalra, J.9
Yapp, D.10
Yan, H.11
Minchinton, A.I.12
Huntsman, D.13
Daynard, T.14
Waterhouse, D.N.15
Thiessen, B.16
Dedhar, S.17
Bally, M.B.18
-
57
-
-
79956188245
-
Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells
-
3097221 21625639
-
Guan H, Song L, Cai J, Huang Y, Wu J, Yuan J, Li J, Li M (2011) Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One 6:e19946
-
(2011)
PLoS One
, vol.6
, pp. 19946
-
-
Guan, H.1
Song, L.2
Cai, J.3
Huang, Y.4
Wu, J.5
Yuan, J.6
Li, J.7
Li, M.8
-
58
-
-
0035736487
-
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
-
11715018
-
Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3:973-982
-
(2001)
Nat Cell Biol
, vol.3
, pp. 973-982
-
-
Zhou, B.P.1
Liao, Y.2
Xia, W.3
Zou, Y.4
Spohn, B.5
Hung, M.C.6
-
59
-
-
0032515027
-
Regulation of cell death protease caspase-9 by phosphorylation
-
9812896
-
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321
-
(1998)
Science
, vol.282
, pp. 1318-1321
-
-
Cardone, M.H.1
Roy, N.2
Stennicke, H.R.3
Salvesen, G.S.4
Franke, T.F.5
Stanbridge, E.6
Frisch, S.7
Reed, J.C.8
-
60
-
-
84875522870
-
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures
-
3587450 23324350
-
Carra E, Barbieri F, Marubbi D, Pattarozzi A, Favoni RE, Florio T, Daga A (2013) Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. Cell Cycle 12:491-500
-
(2013)
Cell Cycle
, vol.12
, pp. 491-500
-
-
Carra, E.1
Barbieri, F.2
Marubbi, D.3
Pattarozzi, A.4
Favoni, R.E.5
Florio, T.6
Daga, A.7
-
61
-
-
34547114987
-
Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation
-
3614065 17513297
-
Kao GD, Jiang Z, Fernandes AM, Gupta AK, Maity A (2007) Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J Biol Chem 282:21206-21212
-
(2007)
J Biol Chem
, vol.282
, pp. 21206-21212
-
-
Kao, G.D.1
Jiang, Z.2
Fernandes, A.M.3
Gupta, A.K.4
Maity, A.5
-
62
-
-
66249149058
-
EGFRvIII and DNA double-strand break repair: A molecular mechanism for radioresistance in glioblastoma
-
2694953 19435898
-
Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, Nannepaga S, Hatanpaa KJ, Mickey B, Madden C, Maher E, Boothman DA, Furnari F, Cavenee WK, Bachoo RM, Burma S (2009) EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res 69:4252-4259
-
(2009)
Cancer Res
, vol.69
, pp. 4252-4259
-
-
Mukherjee, B.1
McEllin, B.2
Camacho, C.V.3
Tomimatsu, N.4
Sirasanagandala, S.5
Nannepaga, S.6
Hatanpaa, K.J.7
Mickey, B.8
Madden, C.9
Maher, E.10
Boothman, D.A.11
Furnari, F.12
Cavenee, W.K.13
Bachoo, R.M.14
Burma, S.15
-
63
-
-
84859856906
-
Gefitinib radiosensitizes stem-like glioma cells: Inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair
-
22516386
-
Kang KB, Zhu C, Wong YL, Gao Q, Ty A, Wong MC (2012) Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair. Int J Radiat Oncol Biol Phys 83:e43-e52
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
-
-
Kang, K.B.1
Zhu, C.2
Wong, Y.L.3
Gao, Q.4
Ty, A.5
Wong, M.C.6
-
64
-
-
79960028514
-
MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks
-
21623170
-
Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG (2011) MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle 10:2218-2232
-
(2011)
Cell Cycle
, vol.10
, pp. 2218-2232
-
-
Fraser, M.1
Harding, S.M.2
Zhao, H.3
Coackley, C.4
Durocher, D.5
Bristow, R.G.6
-
65
-
-
70449687092
-
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha
-
19718046
-
Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949-3959
-
(2009)
Oncogene
, vol.28
, pp. 3949-3959
-
-
Soeda, A.1
Park, M.2
Lee, D.3
Mintz, A.4
Androutsellis-Theotokis, A.5
McKay, R.D.6
Engh, J.7
Iwama, T.8
Kunisada, T.9
Kassam, A.B.10
Pollack, I.F.11
Park, D.M.12
-
66
-
-
60849104091
-
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
-
19208828
-
Gallia GL, Tyler BM, Hann CL, Siu IM, Giranda VL, Vescovi AL, Brem H, Riggins GJ (2009) Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther 8:386-393
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 386-393
-
-
Gallia, G.L.1
Tyler, B.M.2
Hann, C.L.3
Siu, I.M.4
Giranda, V.L.5
Vescovi, A.L.6
Brem, H.7
Riggins, G.J.8
-
67
-
-
84875459340
-
Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation
-
23322009
-
Ran C, Liu H, Hitoshi Y, Israel MA (2013) Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation. Cancer Res 73:1831-1843
-
(2013)
Cancer Res
, vol.73
, pp. 1831-1843
-
-
Ran, C.1
Liu, H.2
Hitoshi, Y.3
Israel, M.A.4
-
68
-
-
79958189212
-
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
-
21618540
-
Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang J, Bian XW (2011) The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 224:344-354
-
(2011)
J Pathol
, vol.224
, pp. 344-354
-
-
Ping, Y.F.1
Yao, X.H.2
Jiang, J.Y.3
Zhao, L.T.4
Yu, S.C.5
Jiang, T.6
Lin, M.C.7
Chen, J.H.8
Wang, B.9
Zhang, R.10
Cui, Y.H.11
Qian, C.12
Wang, J.13
Bian, X.W.14
-
69
-
-
84876844907
-
Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
-
Wei Y, Jiang Y, Zou F, Liu Y, Wang S, Xu N, Xu W, Cui C, Xing Y, Cao B, Liu C, Wu G, Ao H, Zhang X, Jiang J (2013) Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci U S A 110:6829-6834
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 6829-6834
-
-
Wei, Y.1
Jiang, Y.2
Zou, F.3
Liu, Y.4
Wang, S.5
Xu, N.6
Xu, W.7
Cui, C.8
Xing, Y.9
Cao, B.10
Liu, C.11
Wu, G.12
Ao, H.13
Zhang, X.14
Jiang, J.15
-
70
-
-
84875767442
-
IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells
-
23335250
-
Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano S, Matsumura A, Saya H (2013) IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells. Stem Cells 31:627-640
-
(2013)
Stem Cells
, vol.31
, pp. 627-640
-
-
Osuka, S.1
Sampetrean, O.2
Shimizu, T.3
Saga, I.4
Onishi, N.5
Sugihara, E.6
Okubo, J.7
Fujita, S.8
Takano, S.9
Matsumura, A.10
Saya, H.11
-
71
-
-
0032730328
-
Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation
-
10551878
-
Taha C, Liu Z, Jin J, Al-Hasani H, Sonenberg N, Klip A (1999) Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation. J Biol Chem 274:33085-33091
-
(1999)
J Biol Chem
, vol.274
, pp. 33085-33091
-
-
Taha, C.1
Liu, Z.2
Jin, J.3
Al-Hasani, H.4
Sonenberg, N.5
Klip, A.6
-
72
-
-
39049112846
-
AKT signaling in regulating angiogenesis
-
18288940
-
Jiang BH, Liu LZ (2008) AKT signaling in regulating angiogenesis. Curr Cancer Drug Targets 8:19-26
-
(2008)
Curr Cancer Drug Targets
, vol.8
, pp. 19-26
-
-
Jiang, B.H.1
Liu, L.Z.2
-
73
-
-
33846199233
-
Hypoxia-inducible factors: Central regulators of the tumor phenotype
-
3215290 17208433
-
Gordan JD, Simon MC (2007) Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17:71-77
-
(2007)
Curr Opin Genet Dev
, vol.17
, pp. 71-77
-
-
Gordan, J.D.1
Simon, M.C.2
-
74
-
-
0032765047
-
Studies of the molecular mechanisms in the regulation of telomerase activity
-
10593857
-
Liu JP (1999) Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13:2091-2104
-
(1999)
FASEB J
, vol.13
, pp. 2091-2104
-
-
Liu, J.P.1
-
75
-
-
79955731315
-
Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells
-
21557327
-
Das G, Shiras A, Shanmuganandam K, Shastry P (2011) Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol Carcinog 50:412-423
-
(2011)
Mol Carcinog
, vol.50
, pp. 412-423
-
-
Das, G.1
Shiras, A.2
Shanmuganandam, K.3
Shastry, P.4
-
76
-
-
49349113767
-
Runx2 is expressed in human glioma cells and mediates the expression of galectin-3
-
18438928
-
Vladimirova V, Waha A, Luckerath K, Pesheva P, Probstmeier R (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res 86:2450-2461
-
(2008)
J Neurosci Res
, vol.86
, pp. 2450-2461
-
-
Vladimirova, V.1
Waha, A.2
Luckerath, K.3
Pesheva, P.4
Probstmeier, R.5
-
77
-
-
79955520485
-
FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion
-
3108023 21505104
-
Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, Westendorf JJ, Cheng L, Huang H (2011) FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res 71:3257-3267
-
(2011)
Cancer Res
, vol.71
, pp. 3257-3267
-
-
Zhang, H.1
Pan, Y.2
Zheng, L.3
Choe, C.4
Lindgren, B.5
Jensen, E.D.6
Westendorf, J.J.7
Cheng, L.8
Huang, H.9
-
78
-
-
0034642547
-
The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity
-
10644997
-
Morimoto AM, Tomlinson MG, Nakatani K, Bolen JB, Roth RA, Herbst R (2000) The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene 19:200-209
-
(2000)
Oncogene
, vol.19
, pp. 200-209
-
-
Morimoto, A.M.1
Tomlinson, M.G.2
Nakatani, K.3
Bolen, J.B.4
Roth, R.A.5
Herbst, R.6
-
79
-
-
79958831578
-
Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model
-
3118569 21507933
-
Endersby R, Zhu X, Hay N, Ellison DW, Baker SJ (2011) Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model. Cancer Res 71:4106-4116
-
(2011)
Cancer Res
, vol.71
, pp. 4106-4116
-
-
Endersby, R.1
Zhu, X.2
Hay, N.3
Ellison, D.W.4
Baker, S.J.5
-
80
-
-
0242499482
-
Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas
-
14655756
-
Knobbe CB, Reifenberger G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507-518
-
(2003)
Brain Pathol
, vol.13
, pp. 507-518
-
-
Knobbe, C.B.1
Reifenberger, G.2
-
81
-
-
9244227660
-
Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion
-
15557754
-
Pu P, Kang C, Li J, Jiang H (2004) Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion. Tumour Biol 25:172-178
-
(2004)
Tumour Biol
, vol.25
, pp. 172-178
-
-
Pu, P.1
Kang, C.2
Li, J.3
Jiang, H.4
-
82
-
-
30944467414
-
The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo
-
16402276
-
Pu P, Kang C, Li J, Jiang H, Cheng J (2006) The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 76:1-11
-
(2006)
J Neurooncol
, vol.76
, pp. 1-11
-
-
Pu, P.1
Kang, C.2
Li, J.3
Jiang, H.4
Cheng, J.5
-
83
-
-
77953001932
-
AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion
-
20514445
-
Zhang J, Han L, Zhang A, Wang Y, Yue X, You Y, Pu P, Kang C (2010) AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. Oncol Rep 24:65-72
-
(2010)
Oncol Rep
, vol.24
, pp. 65-72
-
-
Zhang, J.1
Han, L.2
Zhang, A.3
Wang, Y.4
Yue, X.5
You, Y.6
Pu, P.7
Kang, C.8
-
84
-
-
67650065524
-
Reduction of Akt2 inhibits migration and invasion of glioma cells
-
19330838
-
Zhang B, Gu F, She C, Guo H, Li W, Niu R, Fu L, Zhang N, Ma Y (2009) Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125:585-595
-
(2009)
Int J Cancer
, vol.125
, pp. 585-595
-
-
Zhang, B.1
Gu, F.2
She, C.3
Guo, H.4
Li, W.5
Niu, R.6
Fu, L.7
Zhang, N.8
Ma, Y.9
-
85
-
-
84864742732
-
Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells
-
22771706
-
Cui Y, Wang Q, Wang J, Dong Y, Luo C, Hu G, Lu Y (2012) Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells. Brain Res 1469:1-9
-
(2012)
Brain Res
, vol.1469
, pp. 1-9
-
-
Cui, Y.1
Wang, Q.2
Wang, J.3
Dong, Y.4
Luo, C.5
Hu, G.6
Lu, Y.7
-
86
-
-
72449164564
-
Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function
-
2783270 19861406
-
Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL (2009) Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res 7:1871-1881
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1871-1881
-
-
Fortin, S.P.1
Ennis, M.J.2
Savitch, B.A.3
Carpentieri, D.4
McDonough, W.S.5
Winkles, J.A.6
Loftus, J.C.7
Kingsley, C.8
Hostetter, G.9
Tran, N.L.10
-
87
-
-
77950050376
-
Increased expression of Akt2 and activity of PI3Kand cell proliferation with the ascending of tumor grade of human gliomas
-
20116920
-
Wang G, Kang C, Pu P (2010) Increased expression of Akt2 and activity of PI3Kand cell proliferation with the ascending of tumor grade of human gliomas. Clin Neurol Neurosurg 112:324-327
-
(2010)
Clin Neurol Neurosurg
, vol.112
, pp. 324-327
-
-
Wang, G.1
Kang, C.2
Pu, P.3
-
88
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
Cancer Genome Atlas Research Network
-
Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
89
-
-
3042823868
-
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
-
15143086
-
Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A, Loeffler JS (2004) The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22:1926-1933
-
(2004)
J Clin Oncol
, vol.22
, pp. 1926-1933
-
-
Chakravarti, A.1
Zhai, G.2
Suzuki, Y.3
Sarkesh, S.4
Black, P.M.5
Muzikansky, A.6
Loeffler, J.S.7
-
90
-
-
84859091170
-
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era
-
3315579 22479427
-
Carico C, Nuno M, Mukherjee D, Elramsisy A, Dantis J, Hu J, Rudnick J, Yu JS, Black KL, Bannykh SI, Patil CG (2012) Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. PLoS One 7:e33684
-
(2012)
PLoS One
, vol.7
, pp. 33684
-
-
Carico, C.1
Nuno, M.2
Mukherjee, D.3
Elramsisy, A.4
Dantis, J.5
Hu, J.6
Rudnick, J.7
Yu, J.S.8
Black, K.L.9
Bannykh, S.I.10
Patil, C.G.11
-
91
-
-
84876736382
-
Targeting the Akt-pathway to improve radiosensitivity in glioblastoma
-
22973963
-
Narayan RS, Fedrigo CA, Stalpers LJ, Baumert BG, Sminia P (2013) Targeting the Akt-pathway to improve radiosensitivity in glioblastoma. Curr Pharm Des 19:951-957
-
(2013)
Curr Pharm des
, vol.19
, pp. 951-957
-
-
Narayan, R.S.1
Fedrigo, C.A.2
Stalpers, L.J.3
Baumert, B.G.4
Sminia, P.5
-
92
-
-
19644373959
-
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence
-
15930307
-
Hirose Y, Katayama M, Mirzoeva OK, Berger MS, Pieper RO (2005) Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res 65:4861-4869
-
(2005)
Cancer Res
, vol.65
, pp. 4861-4869
-
-
Hirose, Y.1
Katayama, M.2
Mirzoeva, O.K.3
Berger, M.S.4
Pieper, R.O.5
-
93
-
-
23844457178
-
Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo
-
16103096
-
Momota H, Nerio E, Holland EC (2005) Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Cancer Res 65:7429-7435
-
(2005)
Cancer Res
, vol.65
, pp. 7429-7435
-
-
Momota, H.1
Nerio, E.2
Holland, E.C.3
-
94
-
-
79953052206
-
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
-
3064692 21317208
-
Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA (2011) Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol 13:384-392
-
(2011)
Neuro Oncol
, vol.13
, pp. 384-392
-
-
Prasad, G.1
Sottero, T.2
Yang, X.3
Mueller, S.4
James, C.D.5
Weiss, W.A.6
Polley, M.Y.7
Ozawa, T.8
Berger, M.S.9
Aftab, D.T.10
Prados, M.D.11
Haas-Kogan, D.A.12
-
95
-
-
42249090359
-
Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma
-
18413797
-
Chen JS, Zhou LJ, Entin-Meer M, Yang X, Donker M, Knight ZA, Weiss W, Shokat KM, Haas-Kogan D, Stokoe D (2008) Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma. Mol Cancer Ther 7:841-850
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 841-850
-
-
Chen, J.S.1
Zhou, L.J.2
Entin-Meer, M.3
Yang, X.4
Donker, M.5
Knight, Z.A.6
Weiss, W.7
Shokat, K.M.8
Haas-Kogan, D.9
Stokoe, D.10
-
96
-
-
77954710908
-
Akt signaling pathway: A target for radiosensitizing human malignant glioma
-
2940626 20406894
-
Chautard E, Loubeau G, Tchirkov A, Chassagne J, Vermot-Desroches C, Morel L, Verrelle P (2010) Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol 12:434-443
-
(2010)
Neuro Oncol
, vol.12
, pp. 434-443
-
-
Chautard, E.1
Loubeau, G.2
Tchirkov, A.3
Chassagne, J.4
Vermot-Desroches, C.5
Morel, L.6
Verrelle, P.7
-
97
-
-
77950232139
-
Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma
-
20197468
-
Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, Hiner RL, Gall S, Huse JT, Jabado N, MacDonald TJ, Holland EC (2010) Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 70:2548-2557
-
(2010)
Cancer Res
, vol.70
, pp. 2548-2557
-
-
Becher, O.J.1
Hambardzumyan, D.2
Walker, T.R.3
Helmy, K.4
Nazarian, J.5
Albrecht, S.6
Hiner, R.L.7
Gall, S.8
Huse, J.T.9
Jabado, N.10
Macdonald, T.J.11
Holland, E.C.12
-
98
-
-
23944453425
-
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study
-
15998902
-
Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J, Peralba JM, Jenkins RB, Dakhil SR, Morton RF, Jaeckle KA, Scheithauer BW, Dancey J, Hidalgo M, Walsh DJ (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23:5294-5304
-
(2005)
J Clin Oncol
, vol.23
, pp. 5294-5304
-
-
Galanis, E.1
Buckner, J.C.2
Maurer, M.J.3
Kreisberg, J.I.4
Ballman, K.5
Boni, J.6
Peralba, J.M.7
Jenkins, R.B.8
Dakhil, S.R.9
Morton, R.F.10
Jaeckle, K.A.11
Scheithauer, B.W.12
Dancey, J.13
Hidalgo, M.14
Walsh, D.J.15
-
99
-
-
21044431575
-
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
-
16012795
-
Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, De Angelis L, Raizer J, Hess K, Aldape K, Lamborn KR, Kuhn J, Dancey J, Prados MD (2005) Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 23:357-361
-
(2005)
Invest New Drugs
, vol.23
, pp. 357-361
-
-
Chang, S.M.1
Wen, P.2
Cloughesy, T.3
Greenberg, H.4
Schiff, D.5
Conrad, C.6
Fink, K.7
Robins, H.I.8
De Angelis, L.9
Raizer, J.10
Hess, K.11
Aldape, K.12
Lamborn, K.R.13
Kuhn, J.14
Dancey, J.15
Prados, M.D.16
-
100
-
-
77957069911
-
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase i study
-
2940647 20156802
-
Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, Musib L, Nicol SJ, Thornton DE, Prados MD (2010) Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study. Neuro Oncol 12:608-613
-
(2010)
Neuro Oncol
, vol.12
, pp. 608-613
-
-
Butowski, N.1
Chang, S.M.2
Lamborn, K.R.3
Polley, M.Y.4
Parvataneni, R.5
Hristova-Kazmierski, M.6
Musib, L.7
Nicol, S.J.8
Thornton, D.E.9
Prados, M.D.10
-
101
-
-
80052820448
-
North Central Cancer Treatment Group Phase i trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme
-
3010479 20864273
-
Sarkaria JN, Galanis E, Wu W, Peller PJ, Giannini C, Brown PD, Uhm JH, McGraw S, Jaeckle KA, Buckner JC (2011) North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 81:468-475
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 468-475
-
-
Sarkaria, J.N.1
Galanis, E.2
Wu, W.3
Peller, P.J.4
Giannini, C.5
Brown, P.D.6
Uhm, J.H.7
McGraw, S.8
Jaeckle, K.A.9
Buckner, J.C.10
-
102
-
-
84876766342
-
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
-
23564811
-
Lassen U, Sorensen M, Gaziel TB, Hasselbalch B, Poulsen HS (2013) Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme. Anticancer Res 33:1657-1660
-
(2013)
Anticancer Res
, vol.33
, pp. 1657-1660
-
-
Lassen, U.1
Sorensen, M.2
Gaziel, T.B.3
Hasselbalch, B.4
Poulsen, H.S.5
-
103
-
-
84880045561
-
RTOG 0913: A phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
-
23725999
-
Chinnaiyan P, Won M, Wen PY, Rojiani AM, Wendland M, Dipetrillo TA, Corn BW, Mehta MP (2013) RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 86:880-884
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.86
, pp. 880-884
-
-
Chinnaiyan, P.1
Won, M.2
Wen, P.Y.3
Rojiani, A.M.4
Wendland, M.5
Dipetrillo, T.A.6
Corn, B.W.7
Mehta, M.P.8
-
104
-
-
67649958571
-
Current status and challenges associated with targeting mTOR for cancer therapy
-
19489650
-
Dowling RJ, Pollak M, Sonenberg N (2009) Current status and challenges associated with targeting mTOR for cancer therapy. BioDrugs 23:77-91
-
(2009)
BioDrugs
, vol.23
, pp. 77-91
-
-
Dowling, R.J.1
Pollak, M.2
Sonenberg, N.3
-
105
-
-
32944457518
-
MTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
3193604 16452206
-
O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, Baselga J, Rosen N (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66:1500-1508
-
(2006)
Cancer Res
, vol.66
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
Solit, D.4
Mills, G.B.5
Smith, D.6
Lane, H.7
Hofmann, F.8
Hicklin, D.J.9
Ludwig, D.L.10
Baselga, J.11
Rosen, N.12
-
106
-
-
65549145048
-
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
-
2658096 19150980
-
Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284:8023-8032
-
(2009)
J Biol Chem
, vol.284
, pp. 8023-8032
-
-
Thoreen, C.C.1
Kang, S.A.2
Chang, J.W.3
Liu, Q.4
Zhang, J.5
Gao, Y.6
Reichling, L.J.7
Sim, T.8
Sabatini, D.M.9
Gray, N.S.10
-
107
-
-
77953452296
-
Biomarker development for the clinical activity of the mTOR inhibitor everolimus (RAD001): Processes, limitations, and further proposals
-
2847314 20360931
-
O'Reilly T, McSheehy PM (2010) Biomarker development for the clinical activity of the mTOR inhibitor everolimus (RAD001): processes, limitations, and further proposals. Transl Oncol 3:65-79
-
(2010)
Transl Oncol
, vol.3
, pp. 65-79
-
-
O'Reilly, T.1
McSheehy, P.M.2
-
108
-
-
77958509195
-
Akt inhibitors in clinical development for the treatment of cancer
-
Pal SK, Reckamp K, Yu H, Figlin RA (2010) Akt inhibitors in clinical development for the treatment of cancer. Exp Opin Invest Drugs 19:1355-1366
-
(2010)
Exp Opin Invest Drugs
, vol.19
, pp. 1355-1366
-
-
Pal, S.K.1
Reckamp, K.2
Yu, H.3
Figlin, R.A.4
-
109
-
-
84862933157
-
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis
-
3302182 22057914
-
Cheng Y, Zhang Y, Zhang L, Ren X, Huber-Keener KJ, Liu X, Zhou L, Liao J, Keihack H, Yan L, Rubin E, Yang JM (2012) MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol Cancer Ther 11:154-164
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 154-164
-
-
Cheng, Y.1
Zhang, Y.2
Zhang, L.3
Ren, X.4
Huber-Keener, K.J.5
Liu, X.6
Zhou, L.7
Liao, J.8
Keihack, H.9
Yan, L.10
Rubin, E.11
Yang, J.M.12
-
110
-
-
84863798210
-
Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells
-
3491642 22532600
-
Makhov PB, Golovine K, Kutikov A, Teper E, Canter DJ, Simhan J, Uzzo RG, Kolenko VM (2012) Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells. Mol Cancer Ther 11:1510-1517
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 1510-1517
-
-
Makhov, P.B.1
Golovine, K.2
Kutikov, A.3
Teper, E.4
Canter, D.J.5
Simhan, J.6
Uzzo, R.G.7
Kolenko, V.M.8
-
111
-
-
84875804031
-
Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models
-
23287563
-
Lin J, Sampath D, Nannini MA, Lee BB, Degtyarev M, Oeh J, Savage H, Guan Z, Hong R, Kassees R, Lee LB, Risom T, Gross S, Liederer BM, Koeppen H, Skelton NJ, Wallin JJ, Belvin M, Punnoose E, Friedman LS, Lin K (2013) Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models. Clin Cancer Res 19:1760-1772
-
(2013)
Clin Cancer Res
, vol.19
, pp. 1760-1772
-
-
Lin, J.1
Sampath, D.2
Nannini, M.A.3
Lee, B.B.4
Degtyarev, M.5
Oeh, J.6
Savage, H.7
Guan, Z.8
Hong, R.9
Kassees, R.10
Lee, L.B.11
Risom, T.12
Gross, S.13
Liederer, B.M.14
Koeppen, H.15
Skelton, N.J.16
Wallin, J.J.17
Belvin, M.18
Punnoose, E.19
Friedman, L.S.20
Lin, K.21
more..
-
113
-
-
28844490209
-
A knotty turnabout? Akt1 as a metastasis suppressor
-
16338656
-
Wyszomierski SL, Yu D (2005) A knotty turnabout? Akt1 as a metastasis suppressor. Cancer Cell 8:437-439
-
(2005)
Cancer Cell
, vol.8
, pp. 437-439
-
-
Wyszomierski, S.L.1
Yu, D.2
|